D. Ross Camidge

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

D. Ross Camidge
Jan 8, 2025, 14:32 | Blog
Aakash Desai: Autogene cevumeran redefining personalized cancer treatment
Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn: "mRNA-based Immunotherapy…
Dec 2, 2024, 10:22 | Blog
Tejas Patil: The efficacy of continuing osimertinib with platinum pemetrexed chemotherapy upon progression in non-small cell lung cancer
Tejas Patil, Thoracic oncologist at University of Colorado Cancer Center, posted on X about recent…
Nov 24, 2024, 13:36 | Insight
Eric K. Singhi: Is it time to universally prescribe 1L lorlatinib for all?
Eric K. Singhi, Assistant Professor in the Department of General Oncology within the Division of…
Nov 22, 2024, 22:09 | Insight
5 papers about Lung Cancer suggested by Stephen Liu
Stephen Liu, Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers…
Sep 19, 2024, 09:23 | Insight
Jessica Lin: Preclinical development and proof-of-concept clinical activity of NVL-655
Jessica Lin shared a post on LinkedIn: "We are pleased to share this article out today…
Aug 27, 2024, 22:06 | Insight
Giuseppe Banna: Promising results for Telisotuzumab Vedotin in advanced NSCLC
Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post on…
Jul 25, 2024, 21:48 | Insight
Stephen V Liu: What is the role for SRS to brain metastases up front for EGFR or ALK NSCLC?
Stephen V Liu shared a paper by Luke R.G. Pike et al. on X, adding: “What…
Jul 25, 2024, 14:02 | Insight
Erman Akkus: Should up-front SRS be added to TKI in brain metastatic EGFR/ALK positive NSCLC?
Erman Akkus, Medical Oncologist at Ankara University, shared a paper by Luke R.G. Pike et al. on…
All: 8 Posts: 1 - 100
Special Coverage